Characterization and Comparison of GITR Expression in Solid Tumors.

Luis VenceSamantha L BucktroutIrina Fernandez CurbeloJorge BlandoBevin M SmithAshley E MahneJohn C LinTerrence ParkEdward PascuaTao SaiJavier Chaparro-RiggersSumit K SubudhiJorge B ScuttiMaria G HigaHao ZhaoShalini S YadavAnirban MaitraIgnacio I WistubaJames P AllisonPadmanee Sharma

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2019)

Human tumor data suggest that NSCLC, renal cell carcinoma, and melanoma should be the tumor subtypes prioritized for anti-GITR therapy development.

Keyphrases

renal cell carcinoma
endothelial cells
small cell lung cancer
poor prognosis
electronic health record
stem cells
big data
advanced non small cell lung cancer
machine learning
binding protein
bone marrow
data analysis
skin cancer
clinical evaluation